Table 2.

Secondary Outcomes at Multiple Time Points Among Participants With LTFU (N = 27)

Health Outcome	M (SD)			Pretreatment vs. LTFU, n = 25–27a			Posttreatment vs. LTFU, n = 25–27a
	Pretreatment	Posttreatment	LTFU	Changeb (SD)	p c	ES [95% CI]	Changeb (SD)	p c	ES [95% CI]
Blood pressure
Systolic	128.9 (18.0)	121.6 (18.1)	121.6 (18.6)	−7.7 (16.8)	.05	−0.4 [−0.8, −0.1]	−1.0 (16.5)	.46	−0.1 [−0.4, 0.3]
Diastolic	75.3 (11.1)	74.1 (9.3)	71.2 (9.5)	−4.2 (10.6)	.09	−0.4 [−0.8, 0.0]	−3.1 (8.8)	.14	−0.3 [−0.7, 0.0]
Weight, kg	80.3 (17.4)	80.3 (17.1)	80.5 (18.0)	0.1 (4.0)	.90	0.0 [−0.1, 0.1]	0.2 (4.8)	.72	0.0 [−0.1, 0.1]
Stress	2.9 (1.5)	2.4 (1.3)	2.4 (1.4)	0.5 (1.3)	.06	−0.3 [−0.6, 0.0]	0 (1.3)	.95	0.0 [−0.4, 0.4]
Sleep disturbance	8.4 (5.1)	7.6 (4.9)	5.8 (4.5)	−2.7 (4.6)	.005	−0.5 [−0.9, −0.2]	−1.7 (3.2)	.004	−0.4 [−0.6, −0.1]
Social roles satisfaction	21.9 (7.8)	25.9 (7.2)	24.9 (8.2)	3.0 (6.8)	.03	0.4 [0.1, 0.7]	−1.0 (5.0)	.38	−0.1 [−0.4, 0.1]
Social activity satisfaction	19.3 (6.2)	22.6 (7.0)	22.3 (7.8)	3.0 (6.3)	.01	0.5 [0.1, 0.9]	−0.3 (5.4)	.72	0.0 [−0.3, 0.2]
Physical activity	1.9 (0.8)	1.8 (0.8)	1.6 (0.8)	0.4 (1.0)	.06	−0.4 [−0.9, 0.0]	−0.2 (1.0)	.35	−0.3 [−0.8, 0.2]

Note. CI = confidence interval; ES = effect size (Cohen’s d ); LTFU = 1-yr long-term follow-up.

^a Sample size varies for each measure because of missing data. ^bChange values may not equal LTFU minus pretreatment or LTFU minus posttreatment because of missing data. ^cWilcoxon signed rank test.